Rituximab-Induced Remission in Epstein-Barr Virus-Associated Glomerulonephritis.
作者信息
Alabdaljabar Mohamad S, Al-Hussain Turki O, Akhtar Mohammed, Conca Walter, Hussein Maged H
机构信息
College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
Department of Pathology, King Faisal Specialist Hospital and Research Center, Riyadh, Kingdom of Saudi Arabia.
出版信息
Kidney Int Rep. 2020 Sep 9;5(11):2109-2113. doi: 10.1016/j.ekir.2020.08.027. eCollection 2020 Nov.
Abstract
摘要
相似文献
1
Rituximab-Induced Remission in Epstein-Barr Virus-Associated Glomerulonephritis.
Kidney Int Rep. 2020 Sep 9;5(11):2109-2113. doi: 10.1016/j.ekir.2020.08.027. eCollection 2020 Nov.
2
A nearly fatal primary Epstein-Barr virus infection associated with low NK-cell counts in a patient receiving azathioprine: a case report and review of literature.
BMC Infect Dis. 2019 May 10;19(1):404. doi: 10.1186/s12879-019-4022-3.
3
Favorable outcome of Epstein-Barr virus-associated B-cell lymphoproliferative disorder complicated by immunoglobulin G4-related disease treated with rituximab-based therapy: a case report.
J Med Case Rep. 2016 Aug 24;10(1):236. doi: 10.1186/s13256-016-1009-1.
4
[The clinical safety and efficacy of low dose rituximab regimen on patients with Epstein-Barr virus infection after allogeneic hematopoietic stem cell transplantation].
Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):592-595. doi: 10.3760/cma.j.issn.0578-1426.2018.08.011.
5
Inflammatory bowel disease exacerbation associated with Epstein-Barr virus infection.
Dis Colon Rectum. 2013 Mar;56(3):322-7. doi: 10.1097/DCR.0b013e31827cd02c.
6
Epstein barr virus hemophagocytic lymphohistiocytosis related to rituximab use and immunopathogenetic insights.
Pathol Res Pract. 2016 Dec;212(12):1194-1198. doi: 10.1016/j.prp.2016.10.003. Epub 2016 Oct 17.
7
Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.
J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):389-93. doi: 10.1097/00005176-200204000-00014.
8
A retrospective analysis on anti-CD20 antibody-treated Epstein-Barr virus-related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantation.
Ann Hematol. 2020 Nov;99(11):2649-2657. doi: 10.1007/s00277-020-04003-8. Epub 2020 Mar 24.
9
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.
Leuk Lymphoma. 2019 Jan;60(1):110-117. doi: 10.1080/10428194.2018.1459603. Epub 2018 Jul 6.
10
Successful preemptive therapy with single-dose rituximab for Epstein-Barr virus infection to prevent post-transplant lymphoproliferative disease after pediatric hematopoietic stem cell transplantation.
Transpl Infect Dis. 2019 Dec;21(6):e13182. doi: 10.1111/tid.13182. Epub 2019 Oct 15.
引用本文的文献
1
Successful treatment with rituximab for central nervous system vasculitis caused by Epstein-Barr virus-associated lymphoproliferative disorder with immunoglobulin M gammopathy.
Encephalitis. 2022 Jan;2(1):14-18. doi: 10.47936/encephalitis.2021.00143. Epub 2021 Nov 15.
本文引用的文献
1
Novel Therapeutics for Epstein⁻Barr Virus.
Molecules. 2019 Mar 12;24(5):997. doi: 10.3390/molecules24050997.
2
Epstein-Barr virus-associated nephrotic syndrome.
Clin Kidney J. 2012 Feb;5(1):50-2. doi: 10.1093/ndtplus/sfr119.
3
Membranoproliferative glomerulonephritis associated with an Epstein-Barr virus infection.
NDT Plus. 2008 Oct;1(5):319-21. doi: 10.1093/ndtplus/sfn098. Epub 2008 Jul 4.
4
Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Haematologica. 2014 Dec;99(12):1846-53. doi: 10.3324/haematol.2014.111104. Epub 2014 Sep 5.
5
Epstein-Barr virus in systemic autoimmune diseases.
Clin Dev Immunol. 2013;2013:535738. doi: 10.1155/2013/535738. Epub 2013 Aug 24.
6
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant.
Blood. 2012 Nov 22;120(22):4292-5. doi: 10.1182/blood-2012-07-445304. Epub 2012 Oct 9.
7
Systemic Epstein-Barr virus infection associated with membranous nephropathy in children.
Clin Nephrol. 2006 Mar;65(3):160-4.
8
Epstein-Barr virus-associated acute renal failure: diagnosis, treatment, and follow-up.
Pediatr Nephrol. 2003 Jul;18(7):667-74. doi: 10.1007/s00467-003-1152-y. Epub 2003 May 15.
9
Epstein-Barr virus-associated acute interstitial nephritis: infection or immunologic phenomenon?
Nephron. 2002 Oct;92(2):437-9. doi: 10.1159/000063320.
Zotero 插件